Researchers from University of Texas Southwestern collaborated with VCU Massey Cancer Center and VCU School of Medicine on the development of a novel drug that increases the sensitivity of deadly brain tumors to radiation. The drug showed remarkable results in extending survival in mouse models of human glioblastoma multiforme (GBM) when given as an adjuvant to radiation therapy.
http://bionews-tx.com/news/2013/05/17/new-brain-cancer-drug-enhances-radiation-treatment-ut-southwestern/
No comments:
Post a Comment